In the BioHarmony Drug Report Database

"Preview" Icon

Tafluprost

Zioptan (tafluprost) is a small molecule pharmaceutical. Tafluprost was first approved as Zioptan on 2012-02-10. It is used to treat open-angle glaucoma in the USA. The pharmaceutical is active against prostaglandin F2-alpha receptor. Zioptan’s patents are valid until 2029-05-28 (FDA).

 

Trade Name

 

Zioptan
 

Common Name

 

tafluprost
 

ChEMBL ID

 

CHEMBL1963683
 

Indication

 

open-angle glaucoma
 

Drug Class

 

Prostaglandins

Image (chem structure or protein)

Tafluprost structure rendering